cbdMD (YCBD) Return on Capital Employed Growth (5y) (2022 - 2025)
cbdMD (YCBD) Return on Capital Employed Growth (5y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn |
| 10 | cbdMD | 4.73 Mn | 1.34 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,643.00 |
| Sep 30, 2025 | -1,405.00 |
| Jun 30, 2025 | -927.00 |
| Mar 31, 2025 | -6,978.00 |
| Dec 31, 2024 | -10,205.00 |
| Sep 30, 2024 | -7,650.00 |
| Jun 30, 2024 | -27,441.00 |
| Mar 31, 2024 | -24,368.00 |
| Dec 31, 2023 | -19,871.00 |
| Sep 30, 2023 | -10,077.00 |
| Jun 30, 2023 | -8,141.00 |
| Mar 31, 2023 | -17,750.00 |
| Dec 31, 2022 | -15,593.00 |
| Sep 30, 2022 | -14,937.00 |